SkinBioTherapeutics plc SBTX.L Stock
SkinBioTherapeutics plc Price Chart
SkinBioTherapeutics plc SBTX.L Financial and Trading Overview
| SkinBioTherapeutics plc stock price | 9.75 GBP |
| Previous Close | 13.38 GBP |
| Open | 13.34 GBP |
| Bid | 12.5 GBP x 0 |
| Ask | 13 GBP x 0 |
| Day's Range | 12.55 - 13.5 GBP |
| 52 Week Range | 11.34 - 30.63 GBP |
| Volume | 158.48K GBP |
| Avg. Volume | 431.13K GBP |
| Market Cap | 21.73M GBP |
| Beta (5Y Monthly) | 2.463601 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SBTX.L Valuation Measures
| Enterprise Value | 20.31M GBP |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 167.42049 |
| Price/Book (mrq) | 1568.8749 |
| Enterprise Value/Revenue | 156.497 |
| Enterprise Value/EBITDA | -6.397 |
Trading Information
SkinBioTherapeutics plc Stock Price History
| Beta (5Y Monthly) | 2.463601 |
| 52-Week Change | -43.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 30.63 GBP |
| 52 Week Low | 11.34 GBP |
| 50-Day Moving Average | 16.23 GBP |
| 200-Day Moving Average | 18.28 GBP |
SBTX.L Share Statistics
| Avg. Volume (3 month) | 431.13K GBP |
| Avg. Daily Volume (10-Days) | 424.87K GBP |
| Shares Outstanding | 173.14M |
| Float | 112.14M |
| Short Ratio | N/A |
| % Held by Insiders | 33.67% |
| % Held by Institutions | 9.16% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2445.90% |
| Gross Margin | 64.47% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -60.11% |
| Return on Equity (ttm) | -111.74% |
Income Statement
| Revenue (ttm) | 129.8K GBP |
| Revenue Per Share (ttm) | 0.001 GBP |
| Quarterly Revenue Growth (yoy) | 250.80% |
| Gross Profit (ttm) | 45.34K GBP |
| EBITDA | -3175164 GBP |
| Net Income Avi to Common (ttm) | -3002678 GBP |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 765.98K GBP |
| Total Cash Per Share (mrq) | 0.005 GBP |
| Total Debt (mrq) | 109.51K GBP |
| Total Debt/Equity (mrq) | 9.03 GBP |
| Current Ratio (mrq) | 1.768 |
| Book Value Per Share (mrq) | 0.008 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2264526 GBP |
| Levered Free Cash Flow (ttm) | -1334520 GBP |
Profile of SkinBioTherapeutics plc
| Country | United Kingdom |
| State | N/A |
| City | Newcastle upon Tyne |
| Address | The Core |
| ZIP | NE4 5TF |
| Phone | 44 19 1495 7325 |
| Website | https://www.skinbiotherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health. It develops SkinBiotix technology that can enhance the formation of multi-protein complexes and prevent passage toxins, molecules, and ions, as well as pathogens; and AxisBiotix that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has a collaboration agreement with Croda Plc; and the University of Manchester to develop bacterial lysates in the prevention of periodontal gun disease. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
Q&A For SkinBioTherapeutics plc Stock
What is a current SBTX.L stock price?
SkinBioTherapeutics plc SBTX.L stock price today per share is 9.75 GBP.
How to purchase SkinBioTherapeutics plc stock?
You can buy SBTX.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SkinBioTherapeutics plc?
The stock symbol or ticker of SkinBioTherapeutics plc is SBTX.L.
Which industry does the SkinBioTherapeutics plc company belong to?
The SkinBioTherapeutics plc industry is Biotechnology.
How many shares does SkinBioTherapeutics plc have in circulation?
The max supply of SkinBioTherapeutics plc shares is 2M.
What is SkinBioTherapeutics plc Price to Earnings Ratio (PE Ratio)?
SkinBioTherapeutics plc PE Ratio is now.
What was SkinBioTherapeutics plc earnings per share over the trailing 12 months (TTM)?
SkinBioTherapeutics plc EPS is -0.02 GBP over the trailing 12 months.
Which sector does the SkinBioTherapeutics plc company belong to?
The SkinBioTherapeutics plc sector is Healthcare.